(8S,9S,10R,13S,14S)-13-Ethyl-11-methylene-1,2,3,6,7,8,9,10,11,12,13,14,15,16-tetradecahydro-17H-cyclopenta[a]phenanthren-17-one (non-preferred name)(CAS: 54024-21-4)

This compound is subject to the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) for hazardous substances. Additionally, it falls under the European Union's Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) regulations. The FDA and EPA in the U.S. may also have specific requirements for its handling and use. Manufacturers and users should consult the SDS and local regulations for detailed guidance.

While this compound is specific, similar chemical structures can often be synthesized using analogous compounds or isomers. Common alternatives include other cyclopentaphenanthrene derivatives or isomeric versions. For instance, 13-ethyl-11-methylene-1,2,3,6,7,8,9,10,11,12,13,14,15,16-tetradecahydro-17H-cyclopenta[a]phenanthren-17-one may serve as a comparable alternative in certain synthesis processes.

Research on this compound is currently focused on its potential applications in pharmaceuticals and synthetic chemistry. Market trends show increasing demand, particularly in the development of novel drug candidates. Studies are ongoing to explore its structural variations and functional properties, which could lead to new applications in various industries.

Waste containing this compound should be collected in a sealed, labeled container and disposed of according to local regulations. Professional incineration or chemical waste disposal services should be utilized. Ensure that all safety precautions are followed, including the use of appropriate personal protective equipment (PPE) and adherence to environmental protection guidelines. Consult the Material Safety Data Sheet (MSDS) and local environmental agencies for specific disposal methods.